LYNGSTADAAS BIOMEDICAL CONSULTING AS

1450 NESODDTANGEN

Finances

Return on Equity

−11,79 %

Current Ratio

0,82

Debt-to-Equity Ratio

0,23

Key figures (NOK)	2022	2021	2020	2019
Revenue	591 000	233 000	295 000	211 000
Net Income	−127 000	149 000	156 000	−430 000
Total Assets	1 471 000	1 526 000	1 361 000	1 192 000
Total Equity	1 077 000	1 204 000	1 055 000	899 000

Income (NOK)	2022	2021	2020	2019
Revenue	591 000	233 000	295 000	211 000
Expenditure	724 000	84 000	155 000	162 000
Operating Profit	−133 000	149 000	140 000	50 000
Financial Income	5 000	0	16 000	2 000
Financial Costs	0	0	0	90 000
Financial Balance	5 000	0	16 000	−88 000
Earnings Before Tax	−127 000	149 000	156 000	−39 000
Tax	0	0	0	391 000
Net Income	−127 000	149 000	156 000	−430 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 353 000	1 337 000	1 336 000	1 063 000
Total Current Assets	118 000	189 000	26 000	129 000
Total Assets	1 471 000	1 526 000	1 361 000	1 192 000
Total Retained Equity	932 000	1 059 000	910 000	754 000
Total Equity	1 077 000	1 204 000	1 055 000	899 000
Total Long-Term Debt	250 000	250 000	250 000	250 000
Total Current Debt	144 000	71 000	56 000	43 000
Total Equity and Debt	1 471 000	1 526 000	1 361 000	1 192 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	591 000	233 000	295 000	211 000
Other Income	0	0	0	0
Revenue	591 000	233 000	295 000	211 000
Cost of Goods Sold	6 000	0	29 000	0
Salary Costs	2 000	5 000	6 000	−1 000
Depreciation	30 000	24 000	4 000	0
Impairment	0	0	0	0
Expenditure	724 000	84 000	155 000	162 000
Operating Profit	−133 000	149 000	140 000	50 000
Financial Income	5 000	0	16 000	2 000
Financial Costs	0	0	0	90 000
Financial Balance	5 000	0	16 000	−88 000
Dividends	0	0	0	0
Net Income	−127 000	149 000	156 000	−430 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	374 000	81 000	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	142 000	131 000	145 000	76 000
Total Tangible Assets	516 000	212 000	145 000	76 000
Total Fiancial Fixed Assets	837 000	1 125 000	1 190 000	987 000
Total Fixed Assets	1 353 000	1 337 000	1 336 000	1 063 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	87 000	5 000	26 000	80 000
Total Current Assets	118 000	189 000	26 000	129 000
Total Assets	1 471 000	1 526 000	1 361 000	1 192 000
Total Equity	1 077 000	1 204 000	1 055 000	899 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	250 000	250 000	250 000	250 000
Creditors	19 000	2 000	1 000	3 000
Unpaid Taxes	1 000	46 000	33 000	35 000
Dividends	0	0	0	0
Other Current Debt	124 000	23 000	22 000	6 000
Total Current Debt	144 000	71 000	56 000	43 000
Total Equity and Debt	1 471 000	1 526 000	1 361 000	1 192 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−11,79 %	12,38 %	14,79 %	−47,83 %
Debt-to-Equity Ratio	0,23	0,21	0,24	0,28
Operating Profit Margin	−22,5 %	63,95 %	47,46 %	23,7 %
Current Ratio	0,82	2,66	0,46	3
Quick Ratio	0,82	2,66	0,46	3
Equity Ratio	0,73	0,79	0,78	0,75
Gross Profit Margin	98,98 %	100 %	90,17 %	100 %